Hepion Pharmaceuticals Stock (NASDAQ: HEPA) stock price, news, charts, stock research, profile.
You can purchase shares of Hepion Pharmaceuticals (NASDAQ:HEPA) through any online brokerage.
Other companies in Hepion Pharmaceuticals’s space includes: 60 Degrees (NASDAQ:SXTP), Kiora Pharmaceuticals (NASDAQ:KPRX), Akanda (NASDAQ:AKAN), Sonoma Pharmaceuticals (NASDAQ:SNOA) and Redhill Biopharma (NASDAQ:RDHL).
Hepion Pharmaceuticals has a consensus price target of $3.50.
The stock price for Hepion Pharmaceuticals (NASDAQ: HEPA) is $0.5035 last updated December 20, 2024 at 8:48 AM EST.
There are no upcoming dividends for Hepion Pharmaceuticals.
Hepion Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 14, 2024.
There is no upcoming split for Hepion Pharmaceuticals.
Hepion Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.